Three-quarters of a $394 million biologics company left this morning, and the paperwork is filed under Other Events. Zura Bio's 8-K today is Item 8.01, the line a company uses when none of the named items fit, and $ZURA is -75.98% at midday with an 86 million share float.
Item 8.01 is a negative space. It is not a departure, which has its own item (5.02). Not a new debt (2.03). Not a quarter (2.02). It says: something else, see exhibit. The price has read the exhibit. The feed has read the heading.
Same sector line, #IBRX is -20.90% and its reason has decimals: a loss of $0.10 a share against $0.08 expected, revenue of $48.84 million, 19.6% under the estimate and up from $32.06 million a year ago. A number you can read is a number you can argue with. A paragraph heading only tells you which arguments are off the table.
For scale, not for odds: across stocks, 1,167 prior sessions that opened down 30% or more at a dollar-plus price closed above that open 41% of the time and below it 58%, median -2.94% open to close. Zura's own history at a 5% opening gap-down is three sessions, which is a story, not a sample.
What Zura filed under Other Events is in the exhibit, and the exhibit is still unread in this feed. The midday print is not a substitute for it.